{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:47:38Z","timestamp":1747205258555,"version":"3.40.5"},"posted":{"date-parts":[[2024,9,6]]},"group-title":"In Review","reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,7,16]]},"abstract":"<title>Abstract<\/title>\n        <p><bold>Background<\/bold> Congenital heart defects can lead to right ventricular (RV) pressure-overload and heart failure. Cell-based therapies, including mesenchymal stromal cells (MSCs) and c-kit positive cells (CPCs) have been studied clinically as options to restore heart function in disease states. Many studies have indicated these cells act through paracrine mechanisms to prevent apoptosis, promote cellular function, and regulate gene\/protein expression. We aimed to determine the proteomic response of diseased hearts to cell therapy<bold>Methods<\/bold> We utilized an animal model of RV pressure overload created by banding the pulmonary artery (PAB). Two weeks post-banding, bone marrow-derived mesenchymal stromal cells (MSCs) and 3 populations of CPCs (nCPCs, cCPCs, ES-CPCs) were delivered to the RV free wall. RV function and cellular retention were measured for four weeks post-injection, at which point hearts were extracted and the RV was excised for liquid chromatography and tandem mass spectrometry. Resulting RV proteomes were compared and analyzed using systems biology and bioinformatics.<bold>Results<\/bold> Proteomic profiling identified 1156 total proteins from the RV, of which 5.97% were significantly changed after PAB. This disease-altered proteome was responsive to cellular therapy, with 72% of the PAB-altered proteome being fully or partially reversed by MSC therapy. This was followed by nCPCs (54%), ES-CPCs (52%), and cCPCs (39%). Systems biology and bioinformatics analysis showed MSC, nCPC, or ES-CPC cell therapy is associated with a decrease in predicted adverse cardiac effects. We also observed an effect of cell therapy on the non-altered RV proteome, however, this was associated with minor predicted pathological endpoints.<bold>Conclusions<\/bold> Our data indicate MSCs, ES-CPCs, and nCPCs significantly reverse the PAB-altered proteome towards a pre-disease state. These results indicate cell-based therapies show promise in improving RV function after pressure overload through partial restoration of the disease-altered cardiac proteome.<\/p>","DOI":"10.21203\/rs.3.rs-4752035\/v1","type":"posted-content","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T09:01:39Z","timestamp":1725613299000},"source":"Crossref","is-referenced-by-count":0,"title":["Cell-based therapies reverse the heart failure-altered right ventricular proteome"],"prefix":"10.21203","author":[{"given":"Nour","family":"Makkaoui","sequence":"first","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhya","family":"Prasad","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritha","family":"Bagchi","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Carmona","sequence":"additional","affiliation":[{"name":"Emory University Emory College of Arts and Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[{"name":"Emory University Emory College of Arts and Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Latham","sequence":"additional","affiliation":[{"name":"Wake Forest Institute for Regenerative Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Wake Forest Institute for Regenerative Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Furdui","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7389-5245","authenticated-orcid":false,"given":"Joshua","family":"Maxwell","sequence":"additional","affiliation":[{"name":"Wake Forest Institute for Regenerative Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1161\/CIRCULATIONAHA.106.183216","article-title":"Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics","volume":"115","author":"Jenkins KJ","year":"2007","unstructured":"Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, Elixson M, Warnes CA, Webb CL, American Heart Association Council on Cardiovascular Disease in the Y. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115(23):2995\u20133014.","journal-title":"Circulation"},{"issue":"10","key":"ref2","first-page":"1","article-title":"The Right Heart in Congenital Heart Disease, Mechanisms and Recent Advances","volume":"8","author":"Guihaire J","year":"2012","unstructured":"Guihaire J, Haddad F, Mercier O, Murphy DJ, Wu JC, Fadel E. The Right Heart in Congenital Heart Disease, Mechanisms and Recent Advances. J Clin experimental Cardiol. 2012;8(10):1\u201311.","journal-title":"J Clin experimental Cardiol"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/hrt.2008.156265","article-title":"Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure","volume":"95","author":"Winter MM","year":"2009","unstructured":"Winter MM, Bouma BJ, Groenink M, Konings TC, Tijssen JGP, van Veldhuisen DJ, Mulder BJM. Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure. Heart. 2009;95(12):960\u20133.","journal-title":"Heart"},{"issue":"17","key":"ref4","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.106.632208","article-title":"Molecular Mechanisms of Right Heart F. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure","volume":"114","author":"Voelkel NF","year":"2006","unstructured":"Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB, National Heart L, Blood Institute Working Group on C. Molecular Mechanisms of Right Heart F. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114(17):1883\u201391.","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ahj.2017.06.009","article-title":"Study design and rationale for ELPIS: A phase I\/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome","volume":"192","author":"Kaushal S","year":"2017","unstructured":"Kaushal S, Wehman B, Pietris N, Naughton C, Bentzen SM, Bigham G, Mishra R, Sharma S, Vricella L, Everett AD, Deatrick KB, Huang S, Mehta H, Ravekes WA, Hibino N, Difede DL, Khan A, Hare JM. Study design and rationale for ELPIS: A phase I\/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome. Am Heart J. 2017;192:48\u201356.","journal-title":"Am Heart J"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3727\/000000005783982558","article-title":"Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats","volume":"14","author":"Zhang S","year":"2005","unstructured":"Zhang S, Jia Z, Ge J, Gong L, Ma Y, Li T, Guo J, Chen P, Hu Q, Zhang P, Liu Y, Li Z, Ma K, Li L, Zhou C. Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats. Cell Transplant. 2005;14(10):787\u201398.","journal-title":"Cell Transplant"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCRESAHA.116.304671","article-title":"Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial","volume":"116","author":"Ishigami S","year":"2015","unstructured":"Ishigami S, Ohtsuki S, Tarui S, Ousaka D, Eitoku T, Kondo M, Okuyama M, Kobayashi J, Baba K, Arai S, Kawabata T, Yoshizumi K, Tateishi A, Kuroko Y, Iwasaki T, Sato S, Kasahara S, Sano S, Oh H. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial. Circul Res. 2015;116(4):653\u201364.","journal-title":"Circul Res"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/CIRCRESAHA.116.310253","article-title":"Intracoronary Cardiac Progenitor Cells in Single Ventricle Physiology: The PERSEUS (Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease) Randomized Phase 2 Trial","volume":"120","author":"Ishigami S","year":"2017","unstructured":"Ishigami S, Ohtsuki S, Eitoku T, Ousaka D, Kondo M, Kurita Y, Hirai K, Fukushima Y, Baba K, Goto T, Horio N, Kobayashi J, Kuroko Y, Kotani Y, Arai S, Iwasaki T, Sato S, Kasahara S, Sano S, Oh H. Intracoronary Cardiac Progenitor Cells in Single Ventricle Physiology: The PERSEUS (Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease) Randomized Phase 2 Trial. Circul Res. 2017;120(7):1162\u201373.","journal-title":"Circul Res"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jtcvs.2015.06.076","article-title":"Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial","volume":"150","author":"Tarui S","year":"2015","unstructured":"Tarui S, Ishigami S, Ousaka D, Kasahara S, Ohtsuki S, Sano S, Oh H. Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial. J Thorac Cardiovasc Surg. 2015;150(5):1198\u2013207. 208.e1-2.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/CIRCRESAHA.117.312311","article-title":"Impact of Cardiac Progenitor Cells on Heart Failure and Survival in Single Ventricle Congenital Heart Disease","volume":"122","author":"Sano T","year":"2018","unstructured":"Sano T, Ousaka D, Goto T, Ishigami S, Hirai K, Kasahara S, Ohtsuki S, Sano S, Oh H. Impact of Cardiac Progenitor Cells on Heart Failure and Survival in Single Ventricle Congenital Heart Disease. Circul Res. 2018;122(7):994\u20131005.","journal-title":"Circul Res"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1002\/clc.20463","article-title":"Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience","volume":"33","author":"Limsuwan A","year":"2010","unstructured":"Limsuwan A, Pienvichit P, Limpijankit T, Khowsathit P, Hongeng S, Pornkul R, Siripornpitak S, Boonbaichaiyapruk S. Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience. Clin Cardiol. 2010;33(8):E7\u201312.","journal-title":"Clin Cardiol"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.healun.2017.01.008","article-title":"A randomized study of autologous bone marrow-derived stem cells in pediatric cardiomyopathy","volume":"36","author":"Pincott ES","year":"2017","unstructured":"Pincott ES, Ridout D, Brocklesby M, McEwan A, Muthurangu V, Burch M. A randomized study of autologous bone marrow-derived stem cells in pediatric cardiomyopathy. J Heart Lung Transpl. 2017;36(8):837\u201344.","journal-title":"J Heart Lung Transpl"},{"issue":"7\u20138","key":"ref13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3727\/000000004783983477","article-title":"Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction","volume":"13","author":"Henning RJ","year":"2004","unstructured":"Henning RJ, Abu-Ali H, Balis JU, Morgan MB, Willing AE, Sanberg PR. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant. 2004;13(7\u20138):729\u201339.","journal-title":"Cell Transplant"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5966\/sctm.2014-0195","article-title":"Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system","volume":"4","author":"Cantero Peral S","year":"2015","unstructured":"Cantero Peral S, Burkhart HM, Oommen S, Yamada S, Nyberg SL, Li X, O'Leary PW, Terzic A, Cannon BC, Nelson TJ. Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system. Stem Cells Transl Med. 2015;4(2):195\u2013206.","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jtcvs.2019.06.001","article-title":"Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections","volume":"158","author":"Burkhart HM","year":"2019","unstructured":"Burkhart HM, Qureshi MY, Rossano JW, Cantero Peral S, O'Leary PW, Hathcock M, Kremers W, Nelson TJ. Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections. J Thorac Cardiovasc Surg. 2019;158(6):1614\u201323.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCRESAHA.116.304671","article-title":"Intracoronary Autologous Cardiac Progenitor Cell Transfer in Patients With Hypoplastic Left Heart Syndrome: The TICAP Prospective Phase 1 Controlled Trial","volume":"116","author":"Ishigami S","year":"2015","unstructured":"Ishigami S, Ohtsuki S, Tarui S, Ousaka D, Eitoku T, Kondo M, Okuyama M, Kobayashi J, Baba K, Arai S, Kawabata T, Yoshizumi K, Tateishi A, Kuroko Y, Iwasaki T, Sato S, Kasahara S, Sano S, Oh H. Intracoronary Autologous Cardiac Progenitor Cell Transfer in Patients With Hypoplastic Left Heart Syndrome: The TICAP Prospective Phase 1 Controlled Trial. Circul Res. 2015;116(4):653\u201364.","journal-title":"Circul Res"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jtcvs.2015.06.076","article-title":"Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial","volume":"150","author":"Tarui S","unstructured":"Tarui S, Ishigami S, Ousaka D, Kasahara S, Ohtsuki S, Sano S, Oh H. Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial. J Thorac Cardiovasc Surg.150(5):1198\u2013e2082.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00246-022-02872-6","article-title":"Autologous Cardiac Stem Cell Injection in Patients with Hypoplastic Left Heart Syndrome (CHILD Study)","volume":"43","author":"Kaushal S","year":"2022","unstructured":"Kaushal S, Hare JM, Shah AM, Pietris NP, Bettencourt JL, Piller LB, Khan A, Snyder A, Boyd RM, Abdullah M, Mishra R, Sharma S, Slesnick TC, Si MS, Chai PJ, Davis BR, Lai D, Davis ME, Mahle WT. Autologous Cardiac Stem Cell Injection in Patients with Hypoplastic Left Heart Syndrome (CHILD Study). Pediatr Cardiol. 2022;43(7):1481\u201393.","journal-title":"Pediatr Cardiol"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/eurjhf\/hfq063","article-title":"New insights into paracrine mechanisms of human cardiac progenitor cells","volume":"12","author":"Maxeiner H","year":"2010","unstructured":"Maxeiner H, Krehbiehl N, Muller A, Woitasky N, Akinturk H, Muller M, Weigand MA, Abdallah Y, Kasseckert S, Schreckenberg R, Schluter KD, Wenzel S. New insights into paracrine mechanisms of human cardiac progenitor cells. Eur J Heart Fail. 2010;12(7):730\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1089\/scd.2012.0602","article-title":"Hypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells","volume":"22","author":"Hsiao ST","year":"2013","unstructured":"Hsiao ST, Lokmic Z, Peshavariya H, Abberton KM, Dusting GJ, Lim SY, Dilley RJ. Hypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells. Stem Cells Dev. 2013;22(10):1614\u201323.","journal-title":"Stem Cells Dev"},{"key":"ref21","article-title":"Exosomal microRNA-21-5p Mediates Mesenchymal Stem Cell Paracrine Effects on Human Cardiac Tissue Contractility","author":"Mayourian J","year":"2018","unstructured":"Mayourian J, Ceholski DK, Gorski P, Mathiyalagan P, Murphy JF, Salazar SI, Stillitano F, Hare JM, Sahoo S, Hajjar RJ, Costa KD. Exosomal microRNA-21-5p Mediates Mesenchymal Stem Cell Paracrine Effects on Human Cardiac Tissue Contractility. Circul Res. 2018.","journal-title":"Circul Res"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/CIRCRESAHA.116.309935","article-title":"Experimental, Systems, and Computational Approaches to Understanding the MicroRNA-Mediated Reparative Potential of Cardiac Progenitor Cell-Derived Exosomes From Pediatric Patients","volume":"120","author":"Agarwal U","year":"2017","unstructured":"Agarwal U, George A, Bhutani S, Ghosh-Choudhary S, Maxwell JT, Brown ME, Mehta Y, Platt MO, Liang Y, Sahoo S, Davis ME. Experimental, Systems, and Computational Approaches to Understanding the MicroRNA-Mediated Reparative Potential of Cardiac Progenitor Cell-Derived Exosomes From Pediatric Patients. Circul Res. 2017;120(4):701\u201312.","journal-title":"Circul Res"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCRESAHA.116.304360","article-title":"Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology","volume":"116","author":"Gray WD","year":"2015","unstructured":"Gray WD, French KM, Ghosh-Choudhary S, Maxwell JT, Brown ME, Platt MO, Searles CD, Davis ME. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circul Res. 2015;116(2):255\u201363.","journal-title":"Circul Res"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.yjmcc.2010.08.005","article-title":"Paracrine mechanisms of stem cell reparative and regenerative actions in the heart","volume":"50","author":"Mirotsou M","year":"2011","unstructured":"Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol. 2011;50(2):280\u20139.","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"883","DOI":"10.5966\/sctm.2015-0241","article-title":"Age-Dependent Effect of Pediatric Cardiac Progenitor Cells After Juvenile Heart Failure","volume":"5","author":"Agarwal U","year":"2016","unstructured":"Agarwal U, Smith AW, French KM, Boopathy AV, George A, Trac D, Brown ME, Shen M, Jiang R, Fernandez JD, Kogon BE, Kanter KR, Alsoufi B, Wagner MB, Platt MO, Davis ME. Age-Dependent Effect of Pediatric Cardiac Progenitor Cells After Juvenile Heart Failure. Stem Cells Translational Med. 2016;5(7):883\u201392.","journal-title":"Stem Cells Translational Med"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/stem.3088","article-title":"Electrical Stimulation of pediatric cardiac-derived c-kit(+) progenitor cells improves retention and cardiac function in right ventricular heart failure","volume":"37","author":"Maxwell JT","year":"2019","unstructured":"Maxwell JT, Trac D, Shen M, Brown ME, Davis ME, Chao MS, Supapannachart KJ, Zaladonis CA, Baker E, Li ML, Zhao J, Jacobs DI. Electrical Stimulation of pediatric cardiac-derived c-kit(+) progenitor cells improves retention and cardiac function in right ventricular heart failure. Stem Cells. 2019;37(12):1528\u201341.","journal-title":"Stem Cells"},{"key":"ref27","article-title":"Aggregation of Child Cardiac Progenitor Cells into Spheres Activates Notch Signaling and Improves Treatment of Right Ventricular Heart Failure","author":"Trac D","year":"2018","unstructured":"Trac D, Maxwell JT, Brown ME, Xu C, Davis ME. Aggregation of Child Cardiac Progenitor Cells into Spheres Activates Notch Signaling and Improves Treatment of Right Ventricular Heart Failure. Circ Res. 2018.","journal-title":"Circ Res"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","article-title":"A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease","volume":"4","author":"Seyfried NT","year":"2017","unstructured":"Seyfried NT, Dammer EB, Swarup V, Nandakumar D, Duong DM, Yin L, Deng Q, Nguyen T, Hales CM, Wingo T, Glass J, Gearing M, Thambisetty M, Troncoso JC, Geschwind DH, Lah JJ, Levey AI. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease. Cell Syst. 2017;4(1):60\u2013e724.","journal-title":"Cell Syst"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13287-015-0044-y","article-title":"Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload","volume":"6","author":"Oommen S","year":"2015","unstructured":"Oommen S, Yamada S, Cantero Peral S, Campbell KA, Bruinsma ES, Terzic A, Nelson TJ. Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload. Stem Cell Res Ther. 2015;6(1):50.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0008-6363(95)00121-2","article-title":"Mechanical and neuroendocrine regulation of the endocrine heart","volume":"31","author":"Bold AJ","year":"1996","unstructured":"de Bold AJ, Bruneau BG, Kuroski de Bold ML. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovascular Res. 1996;31(1):7\u201318.","journal-title":"Cardiovascular Res"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0735-1097(01)01509-1","article-title":"Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes","volume":"38","author":"Lim DS","year":"2001","unstructured":"Lim DS, Roberts R, Marian AJ. Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes. J Am Coll Cardiol. 2001;38(4):1175\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"2000017","DOI":"10.1002\/prca.202000017","article-title":"Cardiomyocyte Proteome Remodeling due to Isoproterenol-Induced Cardiac Hypertrophy during the Compensated Phase","volume":"14","author":"Parreira RC","year":"2020","unstructured":"Parreira RC, G\u00f3mez-Mendoza DP, de Jesus ICG, Lemos RP, Santos AK, Rezende CP, Figueiredo HCP, Pinto MCX, Kjeldsen F, Guatimosim S, Resende RR, Verano-Braga T. Cardiomyocyte Proteome Remodeling due to Isoproterenol-Induced Cardiac Hypertrophy during the Compensated Phase. Proteom \u2013 Clin Appl. 2020;14(4):2000017.","journal-title":"Proteom \u2013 Clin Appl"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jtcvs.2008.09.006","article-title":"Reduction of four-and-a-half LIM-protein 2 expression occurs in human left ventricular failure and leads to altered localization and reduced activity of metabolic enzymes","volume":"137","author":"Bovill E","year":"2009","unstructured":"Bovill E, Westaby S, Crisp A, Jacobs S, Shaw T. Reduction of four-and-a-half LIM-protein 2 expression occurs in human left ventricular failure and leads to altered localization and reduced activity of metabolic enzymes. J Thorac Cardiovasc Surg. 2009;137(4):853\u201361.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41536-020-0091-6","article-title":"Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome","volume":"5","author":"Arrell DK","year":"2020","unstructured":"Arrell DK, Rosenow CS, Yamada S, Behfar A, Terzic A. Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome. npj Regenerative Med. 2020;5(1):5.","journal-title":"npj Regenerative Med"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/sctm.20-0509","article-title":"Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome","volume":"10","author":"Arrell DK","year":"2021","unstructured":"Arrell DK, Crespo-Diaz RJ, Yamada S, Jeon R, Garmany A, Park S, Adolf JP, Livia C, Hillestad ML, Bartunek J, Behfar A, Terzic A. Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome. Stem Cells Transl Med. 2021;10(9):1320\u20138.","journal-title":"Stem Cells Transl Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4752035\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4752035\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T19:23:04Z","timestamp":1731957784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4752035\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":35,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4752035\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s13287-024-04009-3","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,9,6]]},"subtype":"preprint"}}